Quick Answer
Senti Biosciences Holdings, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $22.0 thousand for the year ending 2025.
- This data is from Senti Biosciences Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Senti Biosciences Holdings, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 99.0%.
- Historical annual values: Fiscal year 2025: $22.0 thousand | Fiscal year 2024: $0.00 | Fiscal year 2023: $1.98 million | Fiscal year 2022: $3.29 million | Fiscal year 2021: $2.29 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: